Europe
The companies said they planned to give the government additional time to review the deal. This is the third delay.
Bayer said the award conflicts with an April report from the EPA that says glyphosate, the active ingredient in Roundup, is not a carcinogen.
At the Annual General Meeting in Recipharm AB on May 13, 2019, the shareholders adopted the resolutions summarized
One of the largest, most ethnically diverse studies of Parkinson’s disease to uncover the genetic basis of one of the most common neurodegenerative disorders
BioVaria Start-up Awards go to ISD Immunotech and Mindpax.me
Attend NEXT London 2019 to explore how the European Life Science landscape can embrace digital transformation to stay ahead of regulatory and market developments
Funding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapies
Medtronic plc announced findings from a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, in which a lead is placed outside of the heart and veins to deliver lifesaving defibrillation and anti-tachycardia pacing therapy in one system, with a device the same size as traditional, transvenous ICDs.
A systemically injectable peptide, which may make it possible to restore lost functions in spinal cord injury patients, is moving toward clinical trials in early 2020. It has seen success in animal models.
The company said that its lead product was creating greater-than anticipated kidney injuries in trial patients.
PRESS RELEASES